Ribera, Esteban <br/><br/>
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan.  [electronic resource] 

 -  Enfermedades infecciosas y microbiologia clinica (English ed.)  Mar 2018 
 - 157-164 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2529-993X 
<br/><br/><label>Standard No.: </label>10.1016/j.eimc.2016.11.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Retroviral Agents--economics<br/>Costs and Cost Analysis<br/>Guideline Adherence--economics<br/>HIV Infections--drug therapy<br/>Humans<br/>Practice Guidelines as Topic<br/>Spain<br/>Viral Load